"Superresponders" at biologic treatment for psoriasis: A comparative study among IL17 and IL23 inhibitors.

MLA

Mastorino, Luca, et al. “‘Superresponders’ at Biologic Treatment for Psoriasis: A Comparative Study among IL17 and IL23 Inhibitors.” Experimental Dermatology, vol. 32, no. 12, Dec. 2023, pp. 2187–88. EBSCOhost, https://doi.org/10.1111/exd.14731.

APA

Mastorino, L., Susca, S., Cariti, C., Verrone, A., Stroppiana, E., Ortoncelli, M., Dapavo, P., Ribero, S., & Quaglino, P. (2023). “Superresponders” at biologic treatment for psoriasis: A comparative study among IL17 and IL23 inhibitors. Experimental Dermatology, 32(12), 2187–2188. https://doi.org/10.1111/exd.14731

Chicago

Mastorino, Luca, Sara Susca, Caterina Cariti, Anna Verrone, Elena Stroppiana, Michela Ortoncelli, Paolo Dapavo, Simone Ribero, and Pietro Quaglino. 2023. “‘Superresponders’ at Biologic Treatment for Psoriasis: A Comparative Study among IL17 and IL23 Inhibitors.” Experimental Dermatology 32 (12): 2187–88. doi:10.1111/exd.14731.